We noticed you’re blocking ads

Thanks for visiting CRST Global. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstodayeurope.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Digital Supplement | Editorially independent content, supported with advertising from Nordic Pharma, Glaukos, and Thea

IJC Recap: MIGS and the Cornea, a New Take on Punctal Occlusion, and a Preservative-Free Latanoprost Formulation

Innovation Journal Club explores recently published and presented data around innovations in eye care with a focus on how they might shape real-world practice.

In the Innovation Journal Club (IJC) series on Eyetube.net, host I. Paul Singh, MD, of The Eye Centers of Racine & Kenosha in Wisconsin, interviews leading experts from across eye care subspecialties about emerging innovations and technologies that may prove influential to the real-world practice of ophthalmology. The series is editorially independent (supported by advertising from multiple companies), which allows the discussions to be broad in scope and candid in presentation.

The following is a summary of three episodes in which Dr. Singh spoke with Arsham Sheybani, MD, about corneal endothelial health and MIGS procedures, Brandon Ayres, MD, about a novel crosslinked hyaluronate canalicular gel occlusive for dry eye disease (DED), and Jason Bacharach, MD, about the clinical impact of a preservative-free latanoprost formulation.

author
I. Paul Singh, MD
  • The Eye Centers of Racine & Kenosha
  • Racine & Kenosha, Wisconsin
  • ipsingh@amazingeye.com
  • Financial disclosures: AbbVie/Allergan, Glaukos, Ivantis, New World Medical, Nova Eye Medical, NICOX, iStar Medical, Sight Sciences

NEXT IN THIS ISSUE